92 results on '"Ravasco, Paula"'
Search Results
2. The impact of nutrition on the lives of patients with digestive cancers: a position paper
- Author
-
Vitaloni, Marianna, Caccialanza, Riccardo, Ravasco, Paula, Carrato, Alfredo, Kapala, Aleksandra, de van der Schueren, Marian, Constantinides, Dora, Backman, Eva, Chuter, David, Santangelo, Claudia, and Maravic, Zorana
- Published
- 2022
- Full Text
- View/download PDF
3. Nutritional care in older adults: are we doing everything? An expert opinion review.
- Author
-
Sanchez-Garcia, Elisabet, Cruz-Jentoft, Alfonso J., Ravasco, Paula, Suominen, Merja, and Pitkälä, Prof Kaisu
- Subjects
MUSCLE mass ,OLDER patients ,OLDER people ,NUTRITIONAL assessment ,SKELETAL muscle ,HIP fractures - Abstract
Malnutrition is a prevalent, yet often underdiagnosed and undertreated, condition in older adults. It is characterized by weight loss and/or reduced muscle mass due to diminished caloric intake, inflammation, and/or disease burden. In return, malnutrition can lead to diminished skeletal muscle functionality and disability, among others. Malnutrition plays a crucial role in the pathogenesis of two prevalent geriatric syndromes, namely sarcopenia and frailty. The complex interplay between malnutrition, sarcopenia, and frailty significantly impacts the older population, leading to increased morbidity, mortality, hospitalization rates, quality-of-life, and healthcare costs. Given the prognostic significance of malnutrition in geriatric care, recent guidelines emphasized the role of nutritional support in vulnerable populations. A group of vulnerable populations to malnutrition, sarcopenia, and frailty are older patients with hip fractures, cancer patients, and those with sarcopenic dysphagia. This article highlights the importance of individualized nutritional assessment and treatment in the management of vulnerable populations such as older patients with hip fractures, cancer, and those suffering from sarcopenic dysphagia. It presents practical protocols and guidelines that can be instrumental in enhancing the nutritional care of these groups, thereby improving their overall health outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. The impact of pre-, pro- and synbiotics supplementation in colorectal cancer treatment: a systematic review.
- Author
-
Melo Moreira, Mariana, Carriço, Marta, Luís Capelas, Manuel, Pimenta, Nuno, Santos, Teresa, Ganhão-Arranhado, Susana, Mäkitie, Antti, and Ravasco, Paula
- Abstract
Introduction: The effectiveness of the supplementation of prebiotics, probiotics and synbiotics as a therapeutic approach in colorectal cancer (CRC) remains unclear. The aim of this systematic review is to critically examine the current scientific evidence on the impact of modulating the microbiota, through the use of prebiotics, probiotics and synbiotics, in patients diagnosed with CRC undergoing treatment, to determine the potential therapeutic use of this approach. Methods: This systematic review was made according to the PRISMA 2020 guidelines. Inclusion criteria were randomized controlled trials (RCT) comparing the impact of pre-, pro-, or synbiotic supplementation with placebo or standard care in patients with CRC undergoing treatment. Exclusion criteria were nonhuman studies, non-RCTs, and studies in languages other than English or Portuguese. Six databases were consulted, namely, Cochrane Library, Pubmed, Scopus, Cinahl, MedicLatina and Web of Science until May of 2023. RAYYAN software was used to manage the search results and risk of bias was assessed according to the guidelines of the Cochrane Collaboration using the Rob 2.0 tool. Results: Twenty-four RCTs met the inclusion criteria and were included in this review. Administration of pre-, pro-, or synbiotics improved surgical outcomes such as the incidence of infectious and non-infectious postoperative complications, return to normal gut function, hospital length of stay, and antibiotic usage. The supplementation of these microorganisms also alleviated some symptoms from chemotherapy and radiotherapy, mainly diarrhea. Evidence on the best approach in terms of types of strains, dosage and duration of intervention is still scarce. Conclusions: Pre-, pro-, and synbiotics supplementation appears to be a beneficial therapeutic approach in CRC treatment to improve surgical outcomes and to alleviate side-effects such as treatment toxicity. More RCTs with larger sample sizes and less heterogeneity are needed to confirm these potential benefits and to determine the best strains, dosage, and duration of administration in each situation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. ESPEN guidelines on nutritional support for polymorbid internal medicine patients
- Author
-
Gomes, Filomena, Schuetz, Philipp, Bounoure, Lisa, Austin, Peter, Ballesteros-Pomar, María, Cederholm, Tommy, Fletcher, Jane, Laviano, Alessandro, Norman, Kristina, Poulia, Kalliopi-Anna, Ravasco, Paula, Schneider, Stephane M., Stanga, Zeno, Weekes, C. Elizabeth, and Bischoff, Stephan C.
- Published
- 2018
- Full Text
- View/download PDF
6. ESPEN guidelines on nutrition in cancer patients
- Author
-
Arends, Jann, Bachmann, Patrick, Baracos, Vickie, Barthelemy, Nicole, Bertz, Hartmut, Bozzetti, Federico, Fearon, Ken, Hütterer, Elisabeth, Isenring, Elizabeth, Kaasa, Stein, Krznaric, Zeljko, Laird, Barry, Larsson, Maria, Laviano, Alessandro, Mühlebach, Stefan, Muscaritoli, Maurizio, Oldervoll, Line, Ravasco, Paula, Solheim, Tora, Strasser, Florian, de van der Schueren, Marian, and Preiser, Jean-Charles
- Published
- 2017
- Full Text
- View/download PDF
7. Nutrition Information in Oncology — Extending the Electronic Patient-Record Data Set
- Author
-
Maranhão, Priscila A., Pereira, Ana Margarida, Calhau, Conceição, Ravasco, Paula, Bozzetti, Federico, Laviano, Alessandro, Isenring, Liz, Bandera, Elisa V., B. Huhmann, Maureen, Vieira-Marques, Pedro, and Cruz-Correia, Ricardo J.
- Published
- 2020
- Full Text
- View/download PDF
8. Bioelectrical Impedance Analysis (BIA) for the Assessment of Body Composition in Oncology: A Scoping Review.
- Author
-
Branco, Mariana Garcia, Mateus, Carlota, Capelas, Manuel Luís, Pimenta, Nuno, Santos, Teresa, Mäkitie, Antti, Ganhão-Arranhado, Susana, Trabulo, Carolina, and Ravasco, Paula
- Abstract
Bioelectrical Impedance Analysis (BIA) is a reliable, non-invasive, objective, and cost-effective body composition assessment method, with high reproducibility. This scoping review aims to evaluate the current scientific and clinical evidence on BIA for body composition assessment in oncology patients, under active treatment. Literature search was conducted through MEDLINE, CINAHL, Scopus and Web of Science databases, following PRISMA-ScR Guidelines. Inclusion criteria comprised studies reporting the use of BIA for body composition evaluation in adults with cancer diagnosis. Studies including non-cancer pathology or only assessing nutritional status were excluded. This scoping review comprised a total of 36 studies: 25 were original studies including 18 prospective studies, six cross-sectional studies and one retrospective study and 11 were systematic reviews. Population size for the included original articles ranged from 18 to 1217 participants, comprising a total of 3015 patients with cancer with a mean baseline Body Mass Index (BMI) ranging from 20.3 to 30.0 kg/m
2 and mean age ranging between 47 and 70 years. Review articles included a total of 273 studies, with a total of 78,350 participants. The current review considered studies reporting patients with head and neck cancer (HNC) (n = 8), breast cancer (BC) (n = 4), esophageal cancer (EC) (n = 2), liver cancer (n = 2), pancreatic cancer (PC) (n = 3), gastric cancer (GC) (n = 3), colorectal cancer (CRC) (n = 8), lung cancer (LC) (n = 1), skin cancer (SK) (n = 1) and multiple cancer types (n = 6). BIA is a suitable and valid method for the assessment of body composition in oncology. BIA-derived measures have shown good potential and relevant clinical value in preoperative risk evaluation, in the reduction of postoperative complications and hospital stay and as an important prognostic indicator in persons with cancer. Future research on the diagnostic value and clinical applications of BIA and BIA-derived phase angle (PhA) should be conducted in order to predict its impact on patient survival and other clinical outcomes. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
9. Eicosapentaenoic acid in cancer improves body composition and modulates metabolism
- Author
-
Pappalardo, Giulia, Almeida, Ana, and Ravasco, Paula
- Published
- 2015
- Full Text
- View/download PDF
10. Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy
- Author
-
Ravasco, Paula, Monteiro-Grillo, Isabel, and Camilo, Maria
- Published
- 2012
- Full Text
- View/download PDF
11. Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO).
- Author
-
Muscaritoli, Maurizio, Bar-Sela, Gil, Battisti, Nicolo Matteo Luca, Belev, Borislav, Contreras-Martínez, Jorge, Cortesi, Enrico, de Brito-Ashurst, Ione, Prado, Carla M., Ravasco, Paula, and Yalcin, Suayib
- Subjects
THERAPEUTIC use of antineoplastic agents ,PROFESSIONAL practice ,NUTRITIONAL assessment ,SARCOPENIA ,EVIDENCE-based medicine ,ANTINEOPLASTIC agents ,RISK assessment ,MEDICAL protocols ,CANCER patients ,TREATMENT effectiveness ,MALNUTRITION ,HEALTH care teams ,CACHEXIA ,DECISION making in clinical medicine ,TUMORS ,EARLY diagnosis ,ONCOLOGY ,ALGORITHMS ,IMMUNOTHERAPY ,DISEASE risk factors - Abstract
Simple Summary: Early identification of patients on antineoplastic therapy who are at risk for or already malnourished is critical for optimizing treatment success. Malnourished patients are at increased risk for being unable to tolerate the most effective 'level' and 'duration' of treatment, with grave implications for both the short- (during treatment) and long-term outcomes. Herein, we provide a practical PROtocol for NuTritional risk in Oncology (PRONTO) to enable oncologists to identify patients with or at risk of malnutrition for further evaluation and follow-up with members of the multidisciplinary care team (MDT). Additional guidance is included on the oncologist-led provision of nutritional support if referral to a dietary service is not available. Nutritional issues, including malnutrition, low muscle mass, sarcopenia (i.e., low muscle mass and strength), and cachexia (i.e., weight loss characterized by a continuous decline in skeletal muscle mass, with or without fat loss), are commonly experienced by patients with cancer at all stages of disease. Cancer cachexia may be associated with poor nutritional status and can compromise a patient's ability to tolerate antineoplastic therapy, increase the likelihood of post-surgical complications, and impact long-term outcomes including survival, quality of life, and function. One of the primary nutritional problems these patients experience is malnutrition, of which muscle depletion represents a clinically relevant feature. There have been recent calls for nutritional screening, assessment, treatment, and monitoring as a consistent component of care for all patients diagnosed with cancer. To achieve this, there is a need for a standardized approach to enable oncologists to identify patients commencing and undergoing antineoplastic therapy who are or who may be at risk of malnutrition and/or muscle depletion. This approach should not replace existing tools used in the dietitian's role, but rather give the oncologist a simple nutritional protocol for optimization of the patient care pathway where this is needed. Given the considerable time constraints in day-to-day oncology practice, any such approach must be simple and quick to implement so that oncologists can flag individual patients for further evaluation and follow-up with appropriate members of the multidisciplinary care team. To enable the rapid and routine identification of patients with or at risk of malnutrition and/or muscle depletion, an expert panel of nutrition specialists and practicing oncologists developed the PROtocol for NuTritional risk in Oncology (PRONTO). The protocol enables the rapid identification of patients with or at risk of malnutrition and/or muscle depletion and provides guidance on next steps. The protocol is adaptable to multiple settings and countries, which makes implementation feasible by oncologists and may optimize patient outcomes. We advise the use of this protocol in countries/clinical scenarios where a specialized approach to nutrition assessment and care is not available. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. NRS-2002 for pre-treatment nutritional risk screening and nutritional status assessment in head and neck cancer patients
- Author
-
Orell-Kotikangas, Helena, Österlund, Pia, Saarilahti, Kauko, Ravasco, Paula, Schwab, Ursula, and Mäkitie, Antti A.
- Published
- 2015
- Full Text
- View/download PDF
13. Nutritional risk screening in surgery: Valid, feasible, easy!
- Author
-
Almeida, Ana Isabel, Correia, Marta, Camilo, Maria, and Ravasco, Paula
- Published
- 2012
- Full Text
- View/download PDF
14. Undernutrition and nutritional supplements in Oncology: What do health professionals and caregivers know? – A pilot survey
- Author
-
Ferreira, Catarina, Camilo, Maria, Pena, Rosa, and Ravasco, Paula
- Published
- 2012
- Full Text
- View/download PDF
15. Definition and classification of cancer cachexia: an international consensus
- Author
-
Fearon, Kenneth, Strasser, Florian, Anker, Stefan D, Bosaeus, Ingvar, Bruera, Eduardo, Fainsinger, Robin L, Jatoi, Aminah, Loprinzi, Charles, MacDonald, Neil, Mantovani, Giovanni, Davis, Mellar, Muscaritoli, Maurizio, Ottery, Faith, Radbruch, Lukas, Ravasco, Paula, Walsh, Declan, Wilcock, Andrew, Kaasa, Stein, and Baracos, Vickie E
- Published
- 2011
- Full Text
- View/download PDF
16. Colorectal cancer: Can nutrients modulate NF-κB and apoptosis?
- Author
-
Ravasco, Paula, Aranha, Márcia M., Borralho, Pedro M., Moreira da Silva, Isabel B., Correia, Luís, Fernandes, Afonso, Rodrigues, Cecília M.P., and Camilo, Maria
- Published
- 2010
- Full Text
- View/download PDF
17. Body fat levels in children and adolescents: Effects on the prevalence of obesity
- Author
-
Marques-Vidal, Pedro, Marcelino, Gisela, Ravasco, Paula, Camilo, Maria Ermelinda, and Oliveira, João Miguel
- Published
- 2008
- Full Text
- View/download PDF
18. Protein intake and muscle mass maintenance in patients with cancer types with high prevalence of sarcopenia: a systematic review.
- Author
-
Capitão, Carolina, Coutinho, Diana, Neves, Pedro Miguel, Capelas, Manuel Luís, Pimenta, Nuno M., Santos, Teresa, Mäkitie, Antti, and Ravasco, Paula
- Subjects
MUSCLE mass ,MUSCLE proteins ,SARCOPENIA ,OMEGA-3 fatty acids ,CANCER patients - Abstract
Rationale: Cancer is associated with muscle wasting. However, optimal protein intake has not been determined, limiting the efficacy of nutritional interventions. This systematic review aims to assess the effect of protein intake on muscle mass of patients with cancer types with high prevalence of sarcopenia during treatment, in longitudinal studies. Methods: MEDLINE, CINAHL, and Scopus databases were searched following PRISMA guidelines. Longitudinal studies written in English, including adults with high sarcopenia prevalence cancer diagnosis, submitted to (chemo)radiotherapy, with assessment of protein intake and muscle changes during treatment, published until 4 October 2020 were included. Studies including supplementation with substances, such as n-3 fatty acids, specific amino acids, or proteins, were excluded. Study appraisal was independently conducted by two reviewers, and a qualitative research synthesis was performed. Results: Overall, 575 records were identified, of which, eight studies were included (one randomized clinical trial and seven uncontrolled before and after studies). Patients with head and neck (n = 5), lung (n = 2), and esophageal cancer (n = 1) were included, comprising a total of 554 participants. The studies presented heterogeneous methodologies, objectives, and methods to assess body composition. Overall, participant groups with a mean protein intake below 1.2 g/kg presented muscle wasting, with one exception, while those reporting a mean intake above 1.4 g/kg, maintained muscle during treatment. Conclusions: Our findings show that protein intakes below 1.2 g/kg, even when within the recommendations, have been associated with muscle wasting during treatment. Only intakes above 1.4 g/kg have been associated with muscle maintenance. High-quality research is needed to establish an optimal dose response. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. Cancer: disease and nutrition are key determinants of patients’ quality of life
- Author
-
Ravasco, Paula, Monteiro-Grillo, Isabel, Vidal, Pedro Marques, and Camilo, Maria E.
- Published
- 2004
- Full Text
- View/download PDF
20. The importance of protein sources to support muscle anabolism in cancer: An expert group opinion.
- Author
-
Ford, Katherine L., Arends, Jann, Atherton, Philip J., Engelen, Mariëlle P.K.J., Gonçalves, Thiago J.M., Laviano, Alessandro, Lobo, Dileep N., Phillips, Stuart M., Ravasco, Paula, Deutz, Nicolaas E.P., and Prado, Carla M.
- Abstract
This opinion paper presents a short review of the potential impact of protein on muscle anabolism in cancer, which is associated with better patient outcomes. Protein source is a topic of interest for patients and clinicians, partly due to recent emphasis on the supposed non-beneficial effect of proteins; therefore, misconceptions involving animal-based (e.g., meat, fish, dairy) and plant-based (e.g., legumes) proteins in cancer are acknowledged and addressed. Although the optimal dietary amino acid composition to support muscle health in cancer is yet to be established, animal-based proteins have a composition that offers superior anabolic potential, compared to plant-derived proteins. Thus, animal-based foods should represent the majority (i.e., ≥65%) of protein intake during active cancer treatment. A diet rich in plant-derived proteins may support muscle anabolism in cancer, albeit requiring a larger quantity of protein to fulfill the optimal amino acid intake. We caution that translating dietary recommendations for cancer prevention to cancer treatment may be inadequate to support the pro-inflammatory and catabolic nature of the disease. We further caution against initiating an exclusively plant-based (i.e., vegan) diet upon a diagnosis of cancer, given the presence of elevated protein requirements and risk of inadequate protein intake to support muscle anabolism. Amino acid combination and the long-term sustainability of a dietary pattern void of animal-based foods requires careful and laborious management of protein intake for patients with cancer. Ultimately, a dietary amino acid composition that promotes muscle anabolism is optimally obtained through combination of animal- and plant-based protein sources. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
21. International research program between medical schools: The relevance of clinical research training in nutrition
- Author
-
Stambolliu, Emelina, Bogataj, Jan, Grillo, Isabel Monteiro, Camilo, Maria, and Ravasco, Paula
- Published
- 2012
22. Aspects of taste and compliance in patients with cancer
- Author
-
Ravasco, Paula
- Published
- 2005
- Full Text
- View/download PDF
23. Managing Severe Dysgeusia and Dysosmia in Lung Cancer Patients: A Systematic Scoping Review.
- Author
-
Spencer, Ana Sofia, da Silva Dias, David, Capelas, Manuel Luís, Pimentel, Francisco, Santos, Teresa, Neves, Pedro Miguel, Mäkitie, Antti, and Ravasco, Paula
- Subjects
MUCOSITIS ,LUNG cancer ,TASTE disorders ,SMELL disorders ,CANCER patients ,NUTRITION counseling - Abstract
Introduction: Lung cancer (LC) is highly prevalent worldwide, with elevated mortality. In this population, taste and smell alterations (TSAs) are frequent but overlooked symptoms. The absence of effective therapeutic strategies and evidence-based guidelines constrain TSAs' early recognition, prevention and treatment (Tx), promoting cancer-related malnutrition and jeopardizing survival outcomes and quality of life. Objectives: To systematically review the literature on TSAs in LC patients, understand the physiopathology, identify potential preventive and Tx strategies and to further encourage research in this area. Methods: Literature search on English language articles indexed to PubMed, CINALH, SCOPUS and Web of Science using MeSH terms "Lung neoplasms","Dysgeusia", "Olfaction Disorders", "Carcinoma, Small Cell","Carcinoma, Non- Small-Cell Lung "Adenocarcinoma of Lung","Carcinoma, Large Cell", and non-MeSH terms "Parageusia", "Altered Taste", "Smell Disorder", "Paraosmia", "Dysosmia","Lung Cancer" and "Oat Cell Carcinoma". Results: Thirty-four articles were reviewed. TSAs may follow the diagnosis of LC or develop during cancer Tx. The estimated prevalence of self-reported dysgeusia is 35-38% in treatment-naïve LC patients, and 35-69% in those undergoing Tx, based on studies involving LC patients only. One prospective pilot trial and 1 RCT demonstrated a clinically significant benefit in combining flavor enhancement, smell and taste training and individualized nutritional counselling; a systematic review, 1 RCT and 1 retrospective study favored using intravenous or oral zinc-based solutions (150mg 2-3 times a day) for the prevention and Tx of chemotherapy (CT) and radiotherapy (RT) -induced mucositis and subsequent dysgeusia. Conclusions: This is the first review on dysgeusia and dysosmia in LC patients to our knowledge. We propose combining taste and smell training, personalized dietary counselling and flavor enhancement with oral zinc-based solutions (150mg, 2-3 times a day) during CT and/or RT in this population, in order to prevent and help ameliorate Tx-induced dysgeusia and mucositis. However due to study heterogeneity, the results should be interpreted with caution. Developing standardized TSA measurement tools and performing prospective randomized controlled trials to evaluate their effect are warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. Dietary Counseling Improves Patient Outcomes: A Prospective, Randomized, Controlled Trial in Colorectal Cancer Patients Undergoing Radiotherapy
- Author
-
Ravasco, Paula, Monteiro-Grillo, Isabel, Vidal, Pedro Marques, and Camilo, Maria Ermelinda
- Published
- 2005
- Full Text
- View/download PDF
25. The impact of fluid therapy on nutrient delivery: a prospective evaluation of practice in respiratory intensive care
- Author
-
RAVASCO, PAULA and CAMILO, MARIA ERMELINDA
- Published
- 2003
- Full Text
- View/download PDF
26. ESPEN practical guideline: Clinical Nutrition in cancer.
- Author
-
Muscaritoli, Maurizio, Arends, Jann, Bachmann, Patrick, Baracos, Vickie, Barthelemy, Nicole, Bertz, Hartmut, Bozzetti, Federico, Hütterer, Elisabeth, Isenring, Elizabeth, Kaasa, Stein, Krznaric, Zeljko, Laird, Barry, Larsson, Maria, Laviano, Alessandro, Mühlebach, Stefan, Oldervoll, Line, Ravasco, Paula, Solheim, Tora S., Strasser, Florian, and de van der Schueren, Marian
- Abstract
This practical guideline is based on the current scientific ESPEN guidelines on nutrition in cancer patients. ESPEN guidelines have been shortened and transformed into flow charts for easier use in clinical practice. The practical guideline is dedicated to all professionals including physicians, dieticians, nutritionists and nurses working with patients with cancer. A total of 43 recommendations are presented with short commentaries for the nutritional and metabolic management of patients with neoplastic diseases. The disease-related recommendations are preceded by general recommendations on the diagnostics of nutritional status in cancer patients. This practical guideline gives guidance to health care providers involved in the management of cancer patients to offer optimal nutritional care. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
27. Differing trends in the association between obesity and self-reported health in Portugal and Switzerland. Data from national health surveys 1992–2007
- Author
-
Marques-Vidal Pedro, Ravasco Paula, and Paccaud Fred
- Subjects
Obesity ,Self-rated health ,Population survey ,Trends ,Portugal ,Switzerland ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background The escalating prevalence of obesity might prompt obese subjects to consider themselves as normal, as this condition is gradually becoming as frequent as normal weight. In this study, we aimed to assess the trends in the associations between obesity and self-rated health in two countries. Methods Data from the Portuguese (years 1995–6, 1998–6 and 2005–6) and Swiss (1992–3, 1997, 2002 and 2007) National Health Surveys were used, corresponding to more than 130,000 adults (64,793 for Portugal and 65,829 for Switzerland). Body mass index and self-rated health were derived from self-reported data. Results Obesity levels were higher in Portugal (17.5% in 2005–6 vs. 8.9% in 2007 in Switzerland, p vs 3.9% in 2007, p Conclusion Obesity is increasing in Switzerland and Portugal. Obesity is increasingly associated with poorer self-health ratings in Switzerland but not in Portugal.
- Published
- 2012
- Full Text
- View/download PDF
28. Ten-year trends in overweight and obesity in the adult Portuguese population, 1995 to 2005
- Author
-
Ravasco Paula, Paccaud Fred, and Marques-Vidal Pedro
- Subjects
Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background There is little information regarding the trends in body mass index (BMI) and obesity in the overall Portuguese population, namely if these trends are similar according to educational level. In this study, we assessed the trends in the prevalence of overweight and obesity in the Portuguese population, overall and by educational level. Methods Cross-sectional national health interview surveys conducted in 1995-6 (n = 38,504), 1998-9 (n = 38,688) and 2005-6 (n = 25,348). Data were derived from the population and housing census of 1991 and two geographically-based strata were defined. The sampling unit was the house, and all subjects living in the sampling unit were surveyed. Height and weight were self-reported; the effects of gender, age group and educational level were also assessed by self-reported structured questionnaires. Bivariate comparisons were performed using Chi-square or analysis of variance (ANOVA). Trends in BMI levels were assessed by linear regression analysis, while trends in the prevalence of obesity were assessed by logistic regression. Results Mean (±standard deviation) BMI increased from 25.2 ± 4.0 in 1995-6 to 25.7 ± 4.5 kg/m2 in 2005-6. Prevalence of overweight remained stable (36.1% in 1995-6 and 36.4% in 2005) while prevalence of obesity increased (11.5% in 1995-6 and 15.1% in 2005-6). Similar findings were observed according to age group. Mean age-adjusted BMI increase (expressed in kg/m2/year and 95% confidence interval) was 0.073 (0.062, 0.084), 0.016 (0.000, 0.031) and 0.073 (0.049, 0.098) in men with primary, secondary and university levels, respectively; the corresponding values in women were 0.085 (0.073, 0.097), 0.052 (0.035, 0.069) and 0.062 (0.038, 0.084). Relative to 1995-6, obesity rates increased by 48%, 41% and 59% in men and by 40%, 75% and 177% in women with primary, secondary and university levels, respectively. The corresponding values for overweight were 6%, 1% and 23% in men and 5%, 7% and 65% in women. Conclusion Between 1995 and 2005, obesity increased while overweight remained stable in the adult Portuguese population. Although higher rates were found among lesser educated subjects, the strong increase in BMI and obesity levels in highly educated subjects is of concern.
- Published
- 2011
- Full Text
- View/download PDF
29. Body composition changes in patients with head and neck cancer under active treatment: a scoping review.
- Author
-
Ferrão, Bárbara, Neves, Pedro Miguel, Santos, Teresa, Capelas, Manuel Luís, Mäkitie, Antti, and Ravasco, Paula
- Subjects
BODY composition ,DUAL-energy X-ray absorptiometry ,HEAD & neck cancer ,SKINFOLD thickness ,LEAN body mass ,BODY mass index ,BODY weight - Abstract
Background: Head and neck cancer patients have the second highest malnutrition prevalence, when compared with other oncological patients. They experience significant weight loss before diagnosis, during and after treatment, and even during the first year of follow-up. However, the prognostic value of weight loss depends on body mass index, and this may be associated with low skeletal muscle mass, masking its loss. Thus, weight loss itself poorly predicts outcome in head and neck cancer patients when compared with depleted skeletal muscle mass, illustrating the inadequacy of body mass index as an accurate method to reflect nutritional status. A synthesis is needed of the body composition changes occurring in head and neck cancer patients during treatment, as well as of the methods to assess it. Objective: The aim of this scoping review is to examine and map the body composition changes in head and neck cancer patients under oncological treatment with curative intent. A further objective is to determine which methods are used to assess body composition in these patients. Inclusion criteria: Types of participants: The current review considered head and neck cancer patients, aged 18 years or older. Concept: This scoping review considered all studies that focused on the body composition changes. Context: This scoping review considered the studies that evaluated the body composition changes in the context of treatment with curative intent. Surgical treatment approach was excluded to avoid excess heterogeneity in the data. Types of sources: This scoping review considered only published studies, with abstract available. Search strategy: A three-step search strategy was undertaken. This review was limited to studies published in English, Spanish, and Portuguese during 2000–2019. Data extraction: The data extracted included author(s)/year of publication, aims and purpose of the study, sample size, study design, type of treatment, measurement points and component(s) of body composition evaluated, body composition assessment methods, and main results/findings. Presentation of results: Head and neck cancer patients suffer from serious loss of lean body mass, skeletal muscle, or free fat mass, after treatment compared with baseline. Further, nutritional deterioration is evident and occurs up to 8–12 months after treatment. Bioelectrical impedance analysis is one of the body composition assessment tools that has the great advantage for being available on a regular basis for assessment of body composition in head and neck cancer patients. However, it cannot be recommended for clinical decision making until further validation. Conclusion: Head and neck cancer patients experience a significant depletion of lean body mass, fat-free mass, and skeletal muscle, accompanied by body fat mass, while undergoing (chemo)radiotherapy. This can be demonstrated either by triceps skinfold thickness, bioelectrical impedance analysis, dual-energy x-ray absorptiometry, or computed tomography. This loss has a remarkable impact on their survival, on their quality of life, and on the risk for post-operative complications and may result in a reduced response to cancer treatment. Thus, body composition assessment should become an integral component of the care of head and neck cancer patients, beyond weight and body mass index, and should be carried out at different times throughout treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
30. Body Composition Evaluation in Head and Neck Cancer Patients: A Review.
- Author
-
Almada-Correia, Inês, Neves, Pedro Miguel, Mäkitie, Antti, and Ravasco, Paula
- Subjects
BODY composition ,DUAL-energy X-ray absorptiometry ,BIOELECTRIC impedance ,MUSCLE mass ,CANCER patients ,HEAD & neck cancer - Abstract
Introduction: Head and neck cancer (HNC) patients show a high risk of malnutrition due to the lifestyle habits adopted prior to the diagnosis as well as to the compromising impact of both the anatomical location of the tumor and the treatment modalities on food intake. Weight change, measurement of skinfold thickness, biochemical parameters, bioelectrical impedance analysis (BIA), computed tomography (CT), magnetic resonance (MRI), or dual-energy x-ray absorptiometry (DXA) are available techniques to evaluate nutritional status and/or body composition in the clinical practice. Evaluating body composition alterations in HNC patients is essential to be able to offer the best therapeutical interventions. In this paper, we review the existing literature regarding body composition evaluation in HNC patients to determine, which is the most suitable method for this population, regarding availability in the day-to-day practice, patient burden, cost, sensibility, and specificity. Methodology: A literature search for relevant papers indexed in MEDLINE, Cochrane Library and Scielo was conducted, with no publication date restriction and for all published articles until the 31 January, 2019. All the papers written in English, with interventions in humans, exclusively considering HNC patients were selected. Results: A total of 41 studies with different methodologies were included in this review. In 15 studies BIA was the used assessment method and three of them also evaluated skinfold thickness and one was a bioelectric impedance vector analysis (BIVA). Body composition assessment was made with DXA in eight studies, one of which also included muscle biopsies. In two studies the chosen method was both BIA and DXA. CT/ positron emission tomography-CT was applied in 11 studies and one also included MRI. In two studies body composition was assessed with skinfold measurements alone and one study only used BIVA. Conclusions: Despite the different existing body composition assessment tools, it seems that skeletal muscle mass (SMM) measurement at the level of cervical spine C3 vertebra may be a reliable method for SMM assessment as it strongly correlates with cross-sectional area measures at the level of L3 and it allows a cost-effective body composition assessment without the need for additional radiation exposure. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
31. Cachexia at diagnosis is associated with poor survival in head and neck cancer patients.
- Author
-
Orell-Kotikangas, Helena, Österlund, Pia, Mäkitie, Outi, Saarilahti, Kauko, Ravasco, Paula, Schwab, Ursula, and Mäkitie, Antti A.
- Subjects
CACHEXIA ,HEAD tumors ,NECK tumors ,ANTHROPOMETRY ,GRIP strength ,SURVIVAL ,NUTRITIONAL status ,DIAGNOSIS ,PROGNOSIS - Abstract
Conclusions: One third of the patients had cachexia with an association of significantly shorter survival. These results suggest that combining HGS and MAMA seems to be a practical method to screen cachexia in patients with head and neck cancer and may also be used when assessing their prognosis. Objectives: The aim of this study was to analyze the hypothesis that cachexia defined as both low mid-arm muscle area (MAMA) and handgrip strength (HGS) is associated with decreased survival in patients with head and neck squamous cell carcinoma (HNSCC). Methods: Sixty-five consecutive patients with primary HNSCC were enrolled prior to cancer therapy. Cachexia was defined as low handgrip strength (HGS) and low mid-arm muscle area (MAMA). Nutritional status was assessed by patient-generated subjective global assessment (PG-SGA) and sarco-penia by low MAMA. Biochemical parameters reflecting nutritional status and S-25-OHD were measured. Results: Cachexia was seen in 31% and sarcopenia in 46% of patients. Altogether, 34% of patients were malnourished. Disease-free survival was 13 months (3-62) in cachectic patients, compared with 66 months (31-78) in non-cachectic patients (p - 0.009). S-25-OHD was 28 nmol/l in cachectic patients, compared with 46nmol/l in non-cachectic patients (p - 0.009) and prealbumin 187mg/l and 269mg/l, respectively (p < 0.001 ). [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
32. Weight changes in Portuguese patients with depression: which factors are involved?
- Author
-
Correia, Jerónima and Ravasco, Paula
- Subjects
- *
MENTAL depression , *OBESITY risk factors , *PHYSIOLOGICAL aspects of body weight , *PHYSICAL activity , *PSYCHIATRIC drugs , *INGESTION , *PORTUGUESE people , *HEALTH , *PHYSIOLOGY - Abstract
Background &Aims Depression may lead to obesity, just as obesity can contribute to the disease; yet, changes in the dietary pattern and food habits in depressive syndromes have been scantily investigated. We aimed to identify possible associations between nutritional factors and depressive disorder. Methods This cross sectional study included 127 consecutive ambulatory adult patients with depression (DSM-IV), under psychiatric treatment. All study parameters were classified according to sex & age: BMI, waist circumference, %fat mass, food intake & physical activity. Results Patients' mean age was 48 ± 13 (18-81) yrs, 94% were women. Overweight/obesity was found in 72% of the cohort, 72% had excessive fat mass & 69% had a waist circumference above the maximum cut-off value. Longer disease was associated with higher BMI +%fat mass, p < 0.003. Weight gain during illness was registered in 87%; just 12% lost weight, though undernutrition did not occur. Weight gain and greater fat mass were related with higher BMI, p = 0.002. The pattern of food intake was poor, monotonous and inadequate in 59% of patients; there was also a regular consumption of hypercaloric foods by 78% pts. Overall, the usual diet was associated with weight gain, p = 0.002. Antidepressants (75%) and benzodiazepines (72%) were prevalent; these drugs were associated with weight gain, p = 0.01; 80% pts did not practice any physical activity. Conclusions There was a positive association with overweight/obesity: a striking & clinically worrying prevalence of high fat mass, abdominal fat, weight gain, poor nutritional intake and sedentarism. This unhealthy pattern points towards the need of a multidisciplinary approach to promote healthy lifestyles that may help depressive disorder management. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
33. Length of stay in surgical patients: nutritional predictive parameters revisited.
- Author
-
Almeida, Ana Isabel, Correia, Marta, Camilo, Maria, and Ravasco, Paula
- Subjects
CHI-squared test ,CONFIDENCE intervals ,LENGTH of stay in hospitals ,LONGITUDINAL method ,NUTRITIONAL assessment ,PATIENTS ,PROBABILITY theory ,RISK assessment ,SKINFOLD thickness ,STATISTICS ,SURGERY ,TIME ,WEIGHT loss ,DATA analysis ,EVALUATION research ,BODY mass index ,DISCHARGE planning ,PREDICTIVE tests ,ARM circumference ,DATA analysis software ,NUTRITIONAL status - Abstract
Nutritional evaluation may predict clinical outcomes, such as hospital length of stay (LOS). We aimed to assess the value of nutritional risk and status methods, and to test standard anthropometry percentiles v. the 50th percentile threshold in predicting LOS, and to determine nutritional status changes during hospitalisation and their relation with LOS. In this longitudinal prospective study, 298 surgical patients were evaluated at admission and discharge. At admission, nutritional risk was assessed by Nutritional Risk Screening-2002 (NRS-2002), Malnutrition Universal Screening Tool (MUST) and nutritional status by Subjective Global Assessment (SGA), involuntary % weight loss in the previous 6 months and anthropometric parameters; % weight loss and anthropometry were reassessed at discharge. At admission, risk/undernutrition results by NRS-2002 (P< 0·001), MUST (P< 0·001), % weight loss (P< 0·001) and SGA (P< 0·001) were predictive of longer LOS. A mid-arm circumference (MAC) or a mid-arm muscle circumference (MAMA) under the 15th and the 50th percentile, which was considered indicative of undernutrition, did predict longer LOS (P< 0·001); conversely, there was no association between depleted triceps skinfold (TSF) and longer LOS. In-hospital, there was a high prevalence of weight, muscle and fat losses, associated with longer LOS. At discharge, patients with a simultaneous negative variation in TSF+MAC+MAMA (n 158, 53 %) had longer LOS than patients with a TSF+MAC+MAMA positive variation (11 (8–15) v. 8 (7–12) d, P< 0·001). We concluded that at risk or undernutrition evaluated by all methods, except TSF and BMI, predicted a longer LOS. Moreover, MAC and MAMA measurements and their classification according to the 50th percentile threshold seem reliable undernutrition indicators. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
- Full Text
- View/download PDF
34. What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis?
- Author
-
Pena, Maria João, Ravasco, Paula, Machado, Mariana, Pinto, Anabela, Pinto, Susana, Rocha, Luz, de Carvalho, Mamede, and Pinto, Helena Cortez
- Subjects
- *
PERCUTANEOUS endoscopic gastrostomy , *AMYOTROPHIC lateral sclerosis , *NUTRITIONAL assessment , *BODY mass index , *KAPLAN-Meier estimator , *MULTIVARIATE analysis , *PROGNOSIS - Abstract
Percutaneous endoscopic gastrostomy (PEG) is a standard procedure for feeding dysphagic amyotrophic lateral sclerosis (ALS) patients. Nevertheless, the effect of prognostic factors influencing survival after PEG remains unclear. We aimed to evaluate the prognostic value of several clinical features on survival after PEG placement. This study investigated 151 patients with ALS, in whom a PEG was inserted over the last 16 years in our centre. Survival curves were determined by Kaplan-Meier and the analysis of potential prognostic factors was performed by a Cox regression model. The overall median survival was 32 months, longer in spinal-onset disease patients − 42 vs. 29 months in bulbar-onset patients ( p < 0.001). Median survival after PEG placement was 7.5 months, similar in both bulbar- and spinal-onset patients, 7.9 vs. 7.1 months, respectively. Thirteen percent of patients died within one month after PEG placement; this short-term survival was influenced by low forced vital capacity (FVC < 50%). In a multivariate analysis, only older age at disease onset was independently associated with poor outcome after PEG placement. In conclusion, survival after PEG placement was similar in bulbar- and spinal-onset patients, suggesting that the latter were in a more advanced stage at the time of PEG placement. Low FVC was associated with higher risk of short-term mortality. Older age at disease onset was associated with poorer outcome in bulbar-onset patients. Younger bulbar-onset patients are those who benefited most from PEG. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
35. Validation of the Malnutrition Universal Screening Tool (MUST) in cancer.
- Author
-
Boléo-Tomé, Carolina, Monteiro-Grillo, Isabel, Camilo, Maria, and Ravasco, Paula
- Subjects
NUTRITIONAL assessment ,CHI-squared test ,LONGITUDINAL method ,RESEARCH methodology ,ONCOLOGY ,QUESTIONNAIRES ,RADIOTHERAPY ,RESEARCH evaluation ,STATISTICAL hypothesis testing ,STATISTICS ,WEIGHT loss ,DATA analysis ,BODY mass index ,PREDICTIVE tests ,CROSS-sectional method ,RECEIVER operating characteristic curves ,RESEARCH methodology evaluation ,DATA analysis software ,NUTRITIONAL status - Abstract
In the present study, we aimed to validate the Malnutrition Universal Screening Tool (MUST) for routine nutritional screening in the radiation oncology setting, thus enabling timely and adequate referrals of patients at risk for individualised or advanced intervention. Towards this objective, we conducted a prospective cross-sectional study in 450 non-selected cancer patients (18–95 years) referred for radiotherapy. The following were the nutritional parameters: BMI (categorised by WHO's age/sex criteria), weight loss >5 % in the previous 3–6 months, Patient-Generated Subjective Global Assessment (PG-SGA – validated/specific for oncology) and nutritional risk by MUST. Sensitivity, specificity, predictive values and concordance were calculated to validate MUST v. PG-SGA and compare single parameters v. PG-SGA/MUST. BMI v. PG-SGA showed a negligible capacity to detect undernutrition: 0·27 sensitivity, 0·23 specificity, 0·35 positive predictive value and 0·31 negative predictive value. Conversely, percentage weight loss v. PG-SGA was highly effective: 0·76 sensitivity, 0·85 specificity, 0·79 positive predictive value and 0·85 negative predictive value. MUST v. PG-SGA successfully detected patients at risk: 0·80 sensitivity, 0·89 specificity, 0·87 positive predictive value and 1·0 negative predictive value; percentage weight loss v. MUST proved able to identify patients likely to be at risk: 0·85 sensitivity, 0·91 specificity, 0·90 positive predictive value and 1·0 negative predictive value. This is the first study in the radiation oncology setting to validate MUST: a simple and quick method applicable by any health professional, with a high validity for early screening, ideally to antedate a comprehensive nutritional assessment and guide for intervention. In this study, percentage weight loss in the previous 3–6 months does seem valid to predict nutritional risk, and may be the minimum in a busy routine. [ABSTRACT FROM PUBLISHER]
- Published
- 2012
- Full Text
- View/download PDF
36. A IMPORTÂNCIA DA COMPOSIÇÃO CORPORAL NO DOENTE ONCOLÓGICO.
- Author
-
CORONHA, Ana Lúcia, CAMILO, Maria Ermelinda, and RAVASCO, Paula
- Published
- 2011
37. ALIMENTAÇÃO PARA A SAÚDE.
- Author
-
RAVASCO, Paula, FERREIRA, Catarina, and CAMILO, Maria Ermelinda
- Published
- 2011
38. QUAL A RELEVÂNCIA DA NUTRIÇÃO EM ONCOLOGIA?
- Author
-
de CARVALHO, Gustavo, CAMILO, Maria Ermelinda, and RAVASCO, Paula
- Published
- 2011
39. QUAL O PERFIL NUTRICIONAL E DE ESTILOS DE VIDA DO DOENTE ONCOLÓGICO?
- Author
-
ROLÃO, Andreia, MONTEIRO-GRILLO, Isabel, CAMILO, Maria Ermelinda, and RAVASCO, Paula
- Published
- 2011
40. ESTÁGIO DE INVESTIGAÇÃO EM NUTRIÇÃO.
- Author
-
CORONHA, Ana Lúcia, LOURENÇO, Cláudia, FERREIRA, Marlene, REIS, Nélia, ALMEIDA, Raquel, BOLÉO-TOMÉ, Carolina, MONTEIRO-GRILLO, Isabel, CAMILO, Maria Ermelinda, and RAVASCO, Paula
- Published
- 2011
41. Teaching Nutrition Integration: MUST Screening in Cancer.
- Author
-
BOLÉO-TOMÉ, CAROLINA, CHAVES, MARIANA, MONTEIRO-GRILLO, ISABEL, CAMILO, MARIA, and RAVASCO, PAULA
- Subjects
ALLIED health education ,NUTRITION disorders ,ANALYSIS of variance ,CHI-squared test ,COMPUTER software ,LONGITUDINAL method ,NUTRITIONAL assessment ,PERSONNEL management ,PROBABILITY theory ,RADIOTHERAPY ,RESEARCH funding ,STATISTICS ,DATA analysis ,TEACHING methods ,EDUCATIONAL outcomes ,DIAGNOSIS - Abstract
Rationale. Nutritional risk screening should be routine in order to select patients in need of nutrition care; this conduct change has to rely on education. In this project, radiotherapy department health professionals were trained on how to use the Malnutrition Universal Screening Tool (MUST), to foster its integration into cancer outpatient management; we also aimed to identify those more adherent to screening. Methods. Research dieticians (the standard) conducted interactive sessions with all physicians, nurses, and radiotherapy (RT) technicians, who were closely supervised to facilitate routine MUST integration. There were two phases: after the first session, phase 1 assessed 200 patients over 4 months; after the second session, phase 2 screened 450 patients, always before RT. Validity was evaluated comparing results from the standard against all other health professionals, adjusted for number. Results. RT technicians were most adherent to the MUST: 80% of patients in phase 1, increasing to 85% in phase 2. Nurses doubled their input, from 19% to 36%. Physicians had poor MUST integration, yet they progressively incorporated percentage weight loss into patient records, increasing from 57% in phase 1 to 84% in phase 2, independently of diagnosis and stage. The highest concordance ( coefficient) with dieticians was found with RT technicians' use of the MUST (p < .002) and percentage weight loss determination by physicians (p < .001). Conclusions. We show that systematic screening in cancer is feasible by all professionals involved, once a proximity teaching project is put into practice. RT technicians, who daily treat patients, were highly adherent to integrate the MUST and might be in charge of selecting at-risk patients. Physicians are unlikely to use the MUST, but acknowledged nutrition value and changed their routine by integrating recent percentage weight loss into their approach to patients. Our structured methodology may be used as a model for the development of teaching adapted to different departments with other realities. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
42. The Diversity of Nutritional Status in Cancer: New Insights.
- Author
-
Chaves, Mariana Ramos, Boléo-Tomé, Carolina, Momteiro-Grillo, Isabel, Camilo, Maria, and Ravasco, Paula
- Subjects
HEALTH of cancer patients ,NUTRITIONAL assessment ,BODY mass index ,MALNUTRITION ,ESOPHAGEAL cancer ,PROSTATE cancer - Abstract
Objective. Nutritional status in cancer has been mostly biased toward undernutrition, an issue now in dispute. Weaimed to characterize nutrition status, to analyze associations between nutritional and clinical/cancer-related variables, and to quantify the relative weights of nutritional and cancer-related features. Methods. The cross-sectional study included 450 nonselected cancer patients (ages 18-95 years) at referral for radiotherapy. Nutritional status assessment included recent weight changes, body mass index (BMI categorized by World Health Organization's age/sex criteria, and Patient-Generated Subjective Global Assessment (PG-SGA; validated/specific for oncology).Results. BMI identified 63% as ⩾25 kg/m
2 (43% overweight, 20% obese) and 4% as undernourished. PG-SGA identified 29% as undernourished and 71% as well nourished. Crossing both methods, among the 319 (71%) well-nourished patients according to PG-SGA, 75% were overweight/obese and only 25% were well nourished according to BMI. Concordance between BMI and PG-SGA was evaluated and consistency was confirmed. More aggressive/ advanced stage cancers were more prevalent in deficient and excessive nutritional status: in 83%(n=235/ 282) of overweight/obese patients by BMI and in 85%(n=111/131) of undernourished patients by PG-SGA. Results required adjustment for diagnoses: greater histological aggressiveness was found in overweight/obese prostate and breast cancer; undernutrition was associated with aggressive lung, colorectal, head-neck, stomach, and esophageal cancers (p < .005). Estimates of effect size revealed that overweight/obesity was associated with advanced stage (24%), aggressive breast (10%), and prostate (9%) cancers, whereas undernutrition was associated with more aggressive lung (6%), colorectal (6%), and head neck (6%) cancers; in both instances, age and longer disease duration were of significance. Conclusion. Undernutrition and overweight/obesity have distinct implications and bear a negativeprognosis in cancer. This study provides novel data on the prevalence of overweight/obesity and undernutrition in cancer patients and their potential role in cancer histological behavior. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
43. Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet.
- Author
-
Machado, Maiana Verdelho, Ravasco, Paula, Jesus, Lia, Marques-Vidal, Pedro, Oliveira, Catarina R., Proença, Teresa, Baldeiras, Inês, Camilo, Maria Ermelinda, and Cortez-Pinto, Helena
- Subjects
- *
OXIDATIVE stress , *LIVER diseases , *LIQUID chromatography , *DIET , *GLUTATHIONE , *METABOLISM - Abstract
Objective. Non-alcoholic fatty liver disease is a common condition that can progress to endstage liver disease. The steatotic liver seems to be particularly susceptible to oxidative stress damage. The aim of this study was to evaluate the redox state in patients with non-alcoholic steatohepatitis (NASH) and its correlation with dietary intake. Material and methods. Plasma concentrations of 4-hydroxynonenal (4-HNE), 8-hydroxydeoxyguanosine (8-OHdG), reduced and oxidized glutathione (GSH and GSSG), vitamins A and E, total antioxidant status (TAS), glutathione peroxidase (GSH-Px) and reductase (GSH-Red) erythrocyte activities were compared between 43 NASH patients and 33 healthy controls. 4-HNE, GSH-Px, GSH-Red and TAS were evaluated by spectrophotometry, 8-OHdG by ELISA assay, GSH and GSSG by fluorimetric assay and vitamins A and E by high performance liquid chromatography. Dietary habits were also evaluated in these patients. Results. GSH levels (21.1±18.3 versus 33.1±22.2 µM, p=0.01) and GSH/GSSG ratio (0.9±0.7 versus 1.5±0.8, p=0.01) were lower and TAS (832±146 versus 630±140 µM, p<0.001) and vitamin E (47.1±14.9 versus 34.5±7.3 µM, p<0.001) were higher in NASH patients, although there was no difference in GSH-Px and GSH-Red activities, 8-OHdG and 4-HNE levels between groups. After adjusting for total energy consumption, a negative correlation was found with total and saturated fat intake and GSH/GSSG ratio, and a positive correlation with carbohydrates, fiber, monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), specifically N-3 PUFA, and vitamins E, C, selenium and folate. Conclusions. Our data suggest an impaired glutathione metabolism towards an oxidant status in NASH patients, correlating with a higher intake of saturated fat and a lower intake of carbohydrates. Plasmatic concentrations of oxidative stress cellular markers did not translate to hepatic oxidative damage. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
44. How Relevant Are Cytokines in Colorectal Cancer Wasting?
- Author
-
Ravasco, Paula, Monteiro-Grillo, Isabel, and Camilo, Maria
- Subjects
COLON cancer ,RADIOTHERAPY ,WEIGHT loss ,NUTRITION ,HISTOLOGY ,CYTOKINES - Abstract
Purpose: The purpose of this article was to investigate the influence of inflammatory cytokines, pro-cachectic (interleukin [IL]-1 receptor agonist [IL-1ra], IL-6, and tumor necrosis factor-or [TNF-a]), immunomodulatory (IL-10 and interferon-3, [IFN-3,]), and pro-angiogenic (vascular endothelial growth factor [VEGF]), on resting energy expenditure (REE), weight, and nutritional intake and to explore potential interactions between their circulating concentrations and colorectal cancer stage/histologic differentiation and response to radiotherapy (RT). Patients and Methods: This was a prospective longitudinal study in 101 patients evaluated before and after neoadjuvant RT, including REE (indirect calorimetry), percent weight loss, usual/current diet (diet history and 24-hour recall), serum concentrations of cytokines (enzyme-linked immunosorbent assay), and RT response. Results: Stages III/IV were often associated with histologic grades 2/3 (P < 0.01), albeit both characteristics independently were associated with higher concentrations of IL-1ra (P ≤ 0.05), IL-6 (P ≤ 0.02), TNF-α (P ≤ 0.05), IFN-γ, (P ≤ 0.05), and VEGF (P < 0.03). Before and after RT, higher REE, weight loss ≥5%, and intake reduction ≥25% were associated with advanced stage, histologic grades 2/3, higher IL-1ra, IL-6, TNF-α, IFN-γ, and VEGF, and nonresponse to RT (P = 0.003). A general linear model analysis showed that stages IIUIV, histologic grades 2/3, and higher IL-1ra, IL-6, TNF-α, IFN-γ, and VEGF were major determinants of REE increase, weight loss, and intake reduction. In predictive value analyses, higher baseline pro-cachectic cytokines (IL-1ra + IL-6 + TNF-α) by themselves predicted increased REE (hazard ratio [HR]: 8.25; 95% CI: 2.74-26.47; P < 0.002), greater weight loss (HR: 8.15; 95% CI: 2.22-25.40; P < 0.002), and intake reductions (HR: 7.15; 95% CI: 2.25-16.11; P < 0.004) aider RT. Conclusion: This study confirms the fact that wasting in colorectal cancer is correlated with tumor burden and histologic aggressiveness and suggests that both characteristics lead to overproduction of IFN-γ VEGF, and pro-cachectic cytokines, all of which may cause higher metabolic rates, poor intake, and non-response to RT. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
45. Colorectal Cancer: Intrinsic Characteristics Modulate Cancer Energy Expenditure and the Risk of Cachexia.
- Author
-
Ravasco, Paula, Monteiro-Grillo, Isabel, and Camilo, Maria
- Subjects
- *
COLON cancer patients , *CALORIC expenditure , *ENERGY metabolism , *CACHEXIA , *CANCER patients , *HISTOPATHOLOGY , *CLINICAL medicine research - Abstract
Purpose: To conduct a prospective longitudinal study in colorectal cancer (CRC) patients: 1) to evaluate resting energy expenditure (REE), weight/dietary intake changes, and response to treatment, taking into consideration cancer stage and histology; 2) to determine their potential interrelations; and 3) to quantify the relative contributions to REE of cancer/nutrition/treatment. Patients and Methods: 101 CRC patients proposed for neoadjuvant radiotherapy (RT) were evaluated before and after RT: REE (indirect calorimetry measurements), percentage of weight loss, usual diet (diet history), current diet (24 hour recall), and treatment response. Results: REE was higher in Stages III/IV versus I/II, at the RT onset (p < 0.002) and end (p = 0.02), and in moderately/poorly/undifferentiated cancers vs well differentiated (onset, p < 0.001) and (RT end, p = 0.01); weight/intake reductions were also greater in Stages III/IV versus I/II (p < 0.01) and in moderately/poorly/undifferentiated cancers versus well differentiated (p < 0.02). According to patients' response to treatment, REE was increased in Stage III/IV (p < 0.005) and Grade 2/3 histology (p < 0.003). In nonresponders, REE increased 7.2 ± 1.3 kcal/kg/day and decreased 2.8 ± 0.4 kcal/kg/day in responders. REE changes were not-significantly influenced by weight/intake. Relative contributions to baseline REE were determined in 25 percent by stage, in 25 percent by histology, in 3 percent by intake and in 4 percent by weight loss. At the end of RT, higher REE was attributed in 26 percent to stage, in 27 percent to histology, in 30 percent to nontreatment response, in 9 percent to intake, and in 8 percent to weight loss. Conclusions: In this CRC patient population, higher metabolic rates were mainly determined by the tumor burden and aggressiveness in association with response to treatment clearly disclaiming the effect of weight loss and/or dietary intake reductions. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
46. Cancer wasting and quality of life react to early individualized nutritional counselling!
- Author
-
Ravasco, Paula, Monteiro Grillo, Isabel, and Camilo, Maria
- Abstract
Summary: To devise a meaningful nutritional therapy in cancer, a greater understanding of nutritional dimensions as well as patients’ expectations and disease impact is essential. We have shown that nutritional deterioration in patients with gastrointestinal and head and neck cancer was multifactorial and mainly determined by the tumour burden and location. In a larger cohort, stage and location were yet again the major determinants of patients’ quality of life (QoL), despite the fact that nutritional deterioration combined with intake deficits were functionally more relevant than cancer stage. Based on this framework, the potential role of integrated oral nutritional support on outcomes was investigated. In a pilot study using individualized nutritional counselling on a heterogeneous patient population, the achieved improvement of nutritional intake was proportional to a better QoL. The role of early nutritional support was further analysed in a prospective randomized controlled trial in head and neck cancer patients stratified by stage undergoing radiotherapy. Pre-defined outcomes were: nutritional status and intake, morbidity and QoL, at the end and 3 months after radiotherapy. Nutritional interventions, only given during radiotherapy, consisted of three randomization arms: (1) individualized nutritional counselling vs. (2) ad libitum diet+high protein supplements vs. (3) ad libitum diet. Nutritional interventions 1 and 2 positively influenced outcomes during radiotherapy; however, 3 months after its completion individualized nutritional counselling was the single method capable of sustaining a significant impact on patients’ outcomes. The early provision of the appropriate mixture of foods and textures using regular foods may modulate outcomes in cancer patients. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
47. Foodstuffs and colorectal cancer risk: A review.
- Author
-
Marques-Vidal, Pedro, Ravasco, Paula, and Ermelinda Camilo, Maria
- Abstract
Summary: Background and aims: To assess the relationships between food intake and colorectal cancer risk. Methods: Systematic review of available prospective studies on dietary intake and colorectal cancer. Results: Twelve out of 15 studies found no significant relationship between vegetable intake and colorectal cancer risk; also, 11 out of 14 studies found no relationship with fruit consumption. Conversely, the combined consumption of vegetables and fruit reduced colorectal cancer risk in three out of six studies, although the relationship was somewhat inconsistent between genders and anatomical localizations. Most studies found no relationship between cancer risk and red meat (15 in 20) or processed meat (seven out of 11) consumption; still, most of the reported relative risks were above unity, suggesting that high consumption of red or processed meat might increase colorectal cancer risk. The consumption of white meat, fish/seafood, dairy products, coffee or tea was mostly unrelated to colorectal cancer risk, although the consumption of smoked or salted fish actually increased risk. Conclusions: The relationships between dietary intake and colorectal cancer risk might be less important than previously reported. The combined consumption of vegetables and fruit might be protective, whereas excessive consumption of meat or smoked/salted/processed food appears to be deleterious. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
48. Does nutrition influence quality of life in cancer patients undergoing radiotherapy?
- Author
-
Ravasco, Paula, Monteiro-Grillo, Isabel, and Camilo, Maria Ermelinda
- Subjects
- *
RADIOTHERAPY , *PATIENTS - Abstract
Purpose: To investigate in cancer patients referred for radiotherapy (RT): (1) quality of life (QoL), nutritional status and nutrient intake, at the onset and at the end of RT; (2) whether individualised nutritional counselling, despite symptoms, was able to enhance nutrient intake over time and whether the latter influenced the patient''s QoL; and (3) which symptoms may anticipate poorer QoL and/or reduced nutritional intake.Material and methods: One hundred and twenty-five patients with tumours of the head–neck/gastrointestinal tract (high-risk: HR), prostate, breast, lung, brain, gallbladder, uterus (low-risk: LR) were evaluated before and at the end of RT. Nutritional status was evaluated by Ottery''s Subjective Global Assessment, nutritional intake by a 24-h recall food questionnaire and QoL by two instruments: EUROQOL and the European Organisation for the Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ)-C30.Results: Baseline malnutrition was prevalent in HR vs. LR (
P=0.02 ); nutritional intake was associated with nutritional status (P=0.007 ); the latter did not change significantly during RT. In LR, baseline energy intake was higher than EER (P=0.001 ), and higher than HR’ intake (P=0.002 ); the latter increased (P<0.03 ), in spite of symptom increase anew and/or in severity (P=0.0001 ). According to both instruments, QoL was always better in LR vs. HR (P=0.01 ); at the end of RT, QoL improvement in HR was correlated with increased nutritional intake (P=0.001 ), both remained stable in LR.Conclusions: Individualised nutritional counselling accounting for nutritional status and clinical condition, was able to improve nutritional intake and patients’ QoL, despite self-reported symptoms. [Copyright &y& Elsevier]- Published
- 2003
- Full Text
- View/download PDF
49. Nutrition in Cancer Patients.
- Author
-
Ravasco, Paula
- Subjects
- *
NUTRITIONAL requirements , *NUTRITION counseling , *BODY composition , *OMEGA-3 fatty acids , *NUTRITION - Abstract
Background: Despite being recognised that nutritional intervention is essential, nutritional support is not widely accessible to all patients. Given the incidence of nutritional risk and nutrition wasting, and because cachexia management remains a challenge in clinical practice, a multidisciplinary approach with targeted nutrition is vital to improve the quality of care in oncology. Methods: A literature search in PubMed and Cochrane Library was performed from inception until 26 March. The search consisted of terms on: cancer, nutrition, nutritional therapy, malnutrition, cachexia, sarcopenia, survival, nutrients and guidelines. Key words were linked using "OR" as a Boolean function and the results of the four components were combined by utilizing the "AND" Boolean function. Guidelines, clinical trials and observational studies written in English, were selected. Seminal papers were referenced in this article as appropriate. Relevant articles are discussed in this article. Results: Recent literature supports integration of nutrition screening/assessment in cancer care. Body composition assessment is suggested to be determinant for interventions, treatments and outcomes. Nutritional intervention is mandatory as adjuvant to any treatment, as it improves nutrition parameters, body composition, symptoms, quality of life and ultimately survival. Nutrition counselling is the first choice, with/without oral nutritional supplements (ONS). Criteria for escalating nutrition measures include: (1) 50% of intake vs. requirements for more than 1–2 weeks; (2) if it is anticipated that undernourished patients will not eat and/or absorb nutrients for a long period; (3) if the tumour itself impairs oral intake. N-3 fatty acids are promising nutrients, yet clinically they lack trials with homogeneous populations to clarify the identified clinical benefits. Insufficient protein intake is a key feature in cancer; recent guidelines suggest a higher range of protein because of the likely beneficial effects for treatment tolerance and efficacy. Amino acids for counteracting muscle wasting need further research. Vitamins/minerals are recommended in doses close to the recommended dietary allowances and avoid higher doses. Vitamin D deficiency might be relevant in cancer and has been suggested to be needed to optimise protein supplements effectiveness. Conclusions: A proactive assessment of the clinical alterations that occur in cancer is essential for selecting the adequate nutritional intervention with the best possible impact on nutritional status, body composition, treatment efficacy and ultimately reducing complications and improving survival and quality of life. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
50. Nutritional approaches in cancer: Relevance of individualized counseling and supplementation.
- Author
-
Ravasco, Paula
- Subjects
- *
MALNUTRITION diagnosis , *AGE distribution , *COUNSELING , *DECISION making , *DIETARY supplements , *MEDICAL care , *NUTRITION , *NUTRITIONAL assessment , *PATIENTS , *LEGAL status of patients , *SERIAL publications - Abstract
Intensive individualized nutritional counseling requires nutrition professionals with specific experience in oncology. If the patient is unable to achieve his or her nutritional requirements via regular foods, nutritional supplements may be prescribed, the composition of which is based on detection of dietary deficits as well as a detailed intake questionnaire. Any nutritional intervention must be based on the need for an adequate intake and also must take into consideration other relevant factors such as digestive and absorptive capacity, the need for alleviation or arrest of symptoms, and any psychological issues. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.